NCT05444868 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hatfield AG
Beyond the 10-m time: a pilot study of timed walks in lower limb amputees. Clin Rehabil. 2002 Mar;16(2):210-4. doi: 10.1191/0269215502cr484oa.
Mason K, Chockalingam A, Prudhomme S, Stachenko S, Pearson T
Policy depot: a tool to build global capacity in cardiovascular health policy. Glob Heart. 2012 Mar;7(1):47-51. doi: 10.1016/j.gheart.2012.01.005. Epub 2012 Apr 13. No abstract available.

Validity and Reliability Study of Glittre Activities Of Daily Living Test in Amputees Using Lower Extremity Prosthesis

Clinical trial NCT05444868 - References